Here's the live share price of Norris Medicines along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Norris Medicines | -9.63 | -2.58 | -17.48 | 3.44 | -6.30 | 8.13 | 5.52 |
| Sun Pharmaceutical Industries | -2.10 | -5.16 | -8.61 | 3.18 | 6.85 | 16.44 | 16.32 |
| Divi's Laboratories | 0.53 | -1.47 | 37.17 | 56.83 | 52.38 | 36.19 | 12.70 |
| Torrent Pharmaceuticals | -2.83 | -6.18 | -5.50 | 13.04 | 30.37 | 34.80 | 23.91 |
| Zydus Lifesciences | -2.38 | -0.97 | -3.61 | 23.93 | 12.24 | 23.01 | 15.33 |
| Laurus Labs | 1.90 | 4.84 | 34.83 | 87.06 | 133.64 | 72.00 | 25.94 |
| Cipla | -2.84 | -4.35 | -9.24 | 6.89 | -13.49 | 4.11 | 7.45 |
| Dr. Reddy's Laboratories | -0.42 | 4.53 | -5.89 | -1.43 | -4.07 | 2.82 | 4.08 |
| Mankind Pharma | -6.17 | 4.63 | -6.33 | 15.43 | -4.38 | 10.22 | 10.73 |
| Aurobindo Pharma | -0.99 | -1.87 | 4.53 | 23.81 | 48.21 | 22.13 | 18.15 |
| Lupin | -3.35 | -6.26 | -21.65 | -14.60 | 0.18 | 19.42 | 15.34 |
| Glenmark Pharmaceuticals | -3.09 | -7.19 | -0.05 | 4.38 | 16.97 | 42.42 | 33.54 |
| Alkem Laboratories | 0.55 | 2.51 | -6.71 | -1.87 | -3.78 | 14.08 | 6.06 |
| Biocon | -6.26 | -11.97 | -13.86 | 0.56 | -1.43 | 10.10 | -0.70 |
| Abbott India | -3.50 | 2.66 | -3.25 | 0.36 | -12.76 | 4.08 | 3.28 |
| Gland Pharma | 8.38 | 2.96 | 26.14 | 78.38 | 59.31 | 24.35 | -3.96 |
| Anthem Biosciences | 1.87 | -7.80 | 15.80 | 20.75 | 12.58 | 6.01 | 3.56 |
| Ipca Laboratories | -1.01 | -2.19 | 8.41 | 32.48 | 43.52 | 27.08 | 10.27 |
| GlaxoSmithKline Pharmaceuticals | -8.02 | -11.58 | 4.46 | 8.12 | -7.49 | 18.26 | 11.56 |
| Ajanta Pharma | -5.72 | -4.57 | 2.19 | 22.82 | 39.47 | 24.64 | 17.08 |
Source: Dion Global
Over the last one year, Norris Medicines has declined 6.30% compared to peers like Sun Pharmaceutical Industries (6.85%), Divi's Laboratories (52.38%), Torrent Pharmaceuticals (30.37%). From a 5 year perspective, Norris Medicines has underperformed peers relative to Sun Pharmaceutical Industries (16.32%) and Divi's Laboratories (12.70%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 16.27 | 16.38 |
| 10 | 17.64 | 16.92 |
| 20 | 17.14 | 16.9 |
| 50 | 15.93 | 16.26 |
| 100 | 15.26 | 15.67 |
| 200 | 14.86 | 15.46 |
Source: Dion Global
In the latest quarter, Norris Medicines remained same as its previous close in promoter holding, while DII stake unchanged at 0.07%, FII holding unchanged at 0.00%, and public shareholding unchanged at 65.90% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Sep 30, 2026, 12:26 AM IST IST | Norris Medicines - Scrutinizer''s Report And Voting Results Of The 35Th AGM Of The Company Held 29Th September, 2026 |
| Sep 30, 2026, 12:23 AM IST IST | Norris Medicines - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 29, 2026, 11:03 PM IST IST | Norris Medicines - Outcome And Proceeding Of The 35Th Annual General Meeting |
| Sep 29, 2026, 11:00 PM IST IST | Norris Medicines - Proceeding Of The Annual General Meeting |
| Sep 29, 2026, 10:56 PM IST IST | Norris Medicines - Shareholder Meeting / Postal Ballot-Outcome of AGM |
Source: Dion Global
Norris Medicines Ltd. is a Public Limited Listed company incorporated on 07/09/1990 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1990PLC086581 and registration number is 086581. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 8.13 Cr. and Equity Capital is Rs. 9.93 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Norris Medicines is ₹14.73 as on Oct 09, 2026.
The Norris Medicines is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Norris Medicines is ₹14.73 Cr as on Oct 09, 2026.
Today’s highest and lowest price of Norris Medicines are ₹15.00 and ₹14.73.
The 52-week high/low is the highest and lowest price at which Norris Medicines stock has traded in the past 52-week or nearly a year. The 52-week high of Norris Medicines is ₹20.06 and 52-week low of Norris Medicines is ₹12.00 as on Oct 09, 2026.
The Norris Medicines has shown returns of -4.97% over the past day, -2.58% for the past month, -17.48% over 3 months, -6.3% over 1 year, 8.13% across 3 years, and 5.52% over 5 years.
P/E ratio of and PB ratio of Norris Medicines are -40.25 and -0.95 on Oct 09, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global